Keros stock climbs on Takeda deal effectiveness
-- Keros Therapeutics, Inc. (NASDAQ:KROS) shares rose 6% following the announcement of the effectiveness of its global license agreement with pharmaceutical giant...
-- Keros Therapeutics, Inc. (NASDAQ:KROS) shares rose 6% following the announcement of the effectiveness of its global license agreement with pharmaceutical giant...
-- Jefferies analysts have revised their outlook for major European utilities, upgrading Iberdrola (OTC:IBDRY) and SSE (LON:SSE) to "buy" while downgrading Engie...
-- WillScot (NASDAQ:WSC) Holdings, a prominent player in the industry, has reportedly caught the attention of several private equity firms interested in a potential...
-- UBS analysts remain bullish on Nvidia (NASDAQ:NVDA), dismissing recent market concerns as "overblown." Despite Nvidia's stock largely treading water since its...
-- MicroStrategy, a major player in the business intelligence field, recently bought approximately $1.1 billion worth of bitcoin. The purchase, which took place from...
-- Viasat, Inc. (NASDAQ: VSAT) stock climbed 5% following the company's announcement of being selected for a NASA contract potentially worth $4.8 billion. The...
-- Shares of Walgreens Boots Alliance (NASDAQ:WBA) fell by 6% following allegations by the U.S. Justice Department that the pharmacy chain dispensed millions of...
-- FTAI Aviation's stock fell by 8.8% in premarket trading following the company's announcement that its board has decided to initiate a review. This decision comes...
-- Bank of America released the key findings of its European Fund Manager Survey (FMS) on Tuesday, including rising hopes for a ‘no-landing’ scenario for the global...
-- Wall Street analysts downgraded Apple stock this week, sending its shares sliding more than 2% in premarket trading Tuesday. Analysts at Jefferies slashed their...